Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001873919-24-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-03 | 2024-10-01+ | CADL | Aguilar-Cordova Estuardo | 10% | S - Sale | $6.93 | -22.6K | 961.7K | -2% | -$156.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2024-10-01 | S | A | 6,214 | $7.01 | 988,661 | D | — | — | |
| 2 | Common | CADL | 2024-10-03 | S | D | 1,800 | $6.85 | 959,873 | D | — | — | |
| 3 | Common | CADL | 2024-10-02 | S | D | 26,988 | $6.92 | 961,673 | D | — | — |